(Q53224128)

12 May 2018

title

Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study. (English)

1 reference

12 May 2018

esophageal squamous cell carcinoma

main subject

hypoxia

0 references

1 reference

J Yue

1

1 reference

12 May 2018

Y Yang

2

1 reference

12 May 2018

A R Cabrera

3

1 reference

12 May 2018

X Sun

4

1 reference

12 May 2018

S Zhao

5

1 reference

12 May 2018

P Xie

6

1 reference

12 May 2018

J Zheng

7

1 reference

12 May 2018

L Ma

8

1 reference

12 May 2018

Z Fu

9

1 reference

12 May 2018

J Yu

10

1 reference

12 May 2018

publication date

19 May 2011

1 reference

12 May 2018

Diseases of the Esophagus

published in

1 reference

12 May 2018

volume

25

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

54-61

1 reference

12 May 2018

Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Statistical validation of image segmentation quality based on a spatial overlap index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

ARCON: a novel biology-based approach in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Imaging of tumor hypoxia to predict treatment sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2011.01209.X

10.1111/J.1442-2050.2011.01209.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018